Statement on AstraZeneca Covid-19 vaccine following MHRA update

Statement on AstraZeneca Covid-19 vaccine following MHRA update The Government's statement following updated advice from the UK's medicines regulator. Department of Health and Social Care

See also:

• Independent report: Use of the AstraZeneca COVID-19 vaccine: JCVI statement Department of Health and Social Care
• AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets European Medicines Agency
• MHRA issues new advice, concluding a possible link between COVID-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots Medicines and Healthcare products Regulatory Agency 
• Guidance: COVID-19 vaccination and blood clotting Public Health England
• Guidance: COVID-19 vaccination: blood clotting information for healthcare professionals Public Health England